Target delivery of a gene into the brain using the RVG29-oligoarginine peptide

Biomaterials

Volumn 33, Issue 12, 2012, Pages 3456-3463

  Gong, Cheng ^a,b   Li, Xiangning ^a,b   Xu, Lingling ^a,b   Zhang, Yu Hui ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Brain targeting; DNA delivery; Gene therapy; Peptide vector; RVG29

Indexed keywords

BLOOD-BRAIN BARRIER; BRAIN DISEASE; CLINICAL APPLICATION; DELIVERY SYSTEMS; DNA CARRIER; DNA DELIVERY; DNA DELIVERY SYSTEM; IMMUNOGENICITY; IN-VITRO; IN-VIVO; INTRAVENOUS INJECTIONS; LIPOFECTAMINE; NEW STRATEGY; NON-INVASIVE; NONVIRAL; OLIGOARGININE PEPTIDES; REPORTER-GENE EXPRESSION; RVG29; TARGET DELIVERY; TRANSFECTION REAGENTS;

BIOCOMPATIBILITY; BIODEGRADABLE POLYMERS; BIODEGRADATION; DRUG THERAPY; GENE EXPRESSION; GENE THERAPY; LIPOSOMES; TISSUE;

PEPTIDES;

DNA; LIPID; LIPOFECTAMINE; OLIGOPEPTIDE; POLYMER; REAGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; BRAIN; CELL LINE; CYTOTOXICITY; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ARGININE; BLOOD-BRAIN BARRIER; BRAIN; CELL LINE, TUMOR; CELLS, CULTURED; DNA; GENE TARGETING; MICE; MOLECULAR SEQUENCE DATA; NEURONS; PEPTIDES; RATS; RATS, WISTAR; TRANSFECTION;

MUS;

EID: 84862807323     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.12.017     Document Type: Article

References (43)

1. Schlachetzki F., Zhang Y., Boado R.J., Pardridge W.M. Gene therapy of the brain. Neurology 2004, 62:1275-1281.
2. Teixido M., Giralt E. The role of peptides in blood-brain barrier nanotechnology. J Pept Sci 2008, 14:163-173.
3. Mochizuki H., Yasuda T., Mouradian M.M. Advances in gene therapy for movement disorders. Neurotherapeutics 2008, 5:260-269.
4. Pardridge W.M. Drug and gene delivery to the brain: the vascular route. Neuron 2002, 36:555-558.
5. Liu Y., Huang R., Jiang C. Non-viral gene delivery and therapeutics targeting to brain. Curr Nanosci 2011, 7:55-70.
6. Pardridge W.M. Blood-brain barrier delivery of protein and non-viral gene therapeutics with molecular trojan horses. J Control Release 2007, 122:345-348.
7. Breakefield X.O., Sena-Esteves M. Healing genes in the nervous system. Neuron 2010, 68:178-181.
8. Anliker B., Abel T., Kneissl S., Hlavaty J., Caputi A., Brynza J., et al. Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors. Nat Methods 2010, 7:929-935.
9. Chen S.H., Shine H.D., Goodman J.C., Grossman R.G., Woo S. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci U S A 1994, 91:3054-3057.
10. Lehrman S. Virus treatment questioned after gene therapy death. Nature 1999, 401:517-518.
11. Kim P.H., Kim T., Yockman J.W., Kim S.W., Yun C.O. The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy. Biomaterials 2010, 31:1865-1874.
12. Mintzer M.A., Simanek E.E. Nonviral vectors for gene delivery. Chem Rev 2008, 109:259-302.
13. Zhang H., Vinogradov S.V. Short biodegradable polyamines for gene delivery and transfection of brain capillary endothelial cells. J Control Release 2010, 143:359-366.
14. Karra D., Dahm R. Transfection techniques for neuronal cells. J Neurosci 2010, 30:6171-6177.
15. Bergen J.M., Park I.K., Horner P.J., Pun S.H. Nonviral approaches for neuronal delivery of nucleic acids. Pharm Res 2008, 25:983-998.
16. Ke W., Shao K., Huang R., Han L., Liu Y., Li J., et al. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. Biomaterials 2009, 30:6976-6985.
17. Oliveira H., Fernandez R., Pires L.R., Martins M.C.L., Simoes S., Barbosa M.A., et al. Targeted gene delivery into peripheral sensorial neurons mediated by self-assembled vectors composed of poly (ethylene imine) and tetanus toxin fragment c. J Control Release 2010, 143:350-358.
18. Kwon E.J., Lasiene J., Jacobson B.E., Park I.K., Horner P.J., Pun S.H. Targeted nonviral delivery vehicles to neural progenitor cells in the mouse subventricular zone. Biomaterials 2010, 31:2417-2424.
19. Liu Y., Li J., Shao K., Huang R., Ye L., Lou J., et al. A leptin derived 30-amino-acid peptide modified pegylated poly-l-lysine dendrigraft for brain targeted gene delivery. Biomaterials 2010, 31:5246-5257.
20. Liu Y., Huang R., Han L., Ke W., Shao K., Ye L., et al. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. Biomaterials 2009, 30:4195-4202.
21. Son S., Hwang D.W., Singha K., Jeong J.H., Park T.G., Lee D.S., et al. RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain. J Control Release 2011, 155:18-25.
22. Lv H., Zhang S., Wang B., Cui S., Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release 2006, 114:100-109.
23. Fonseca S.B., Pereira M.P., Kelley S.O. Recent advances in the use of cell-penetrating peptides for medical and biological applications. Adv Drug Deliv Rev 2009, 61:953-964.
24. Martin M.E., Rice K.G. Peptide-guided gene delivery. AAPS J 2007, 9:18-29.
25. Seow W.Y., Yang Y.Y., George A.J.T. Oligopeptide-mediated gene transfer into mouse corneal endothelial cells: expression, design optimization, uptake mechanism and nuclear localization. Nucleic Acids Res 2009, 37:6276-6289.
26. Wang H.Y., Chen J.X., Sun Y.X., Deng J.Z., Li C., Zhang X.Z., et al. Construction of cell penetrating peptide vectors with N-terminal stearylated nuclear localization signal for targeted delivery of DNA into the cell nuclei. J Control Release 2011, 155:26-33.
27. Khalil I., Futaki S., Niwa M., Baba Y., Kaji N., Kamiya H., et al. Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation. Gene Ther 2004, 11:636-644.
28. Lentz T.L., Burrage T.G., Smith A.L., Crick J., Tignor G.H. Is the acetylcholine receptor a rabies virus receptor?. Science 1982, 215:182-184.
29. Lafon M. Rabies virus receptors. J Neurovirol 2005, 11:82-87.
30. Kumar P., Wu H., McBride J.L., Jung K.E., Kim M.H., Davidson B.L., et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007, 448:39-43.
31. Seow W.Y., Yang Y.Y. A class of cationic triblock amphiphilic oligopeptides as efficient gene-delivery vectors. Adv Mater 2009, 21:86-90.
32. Serikawa T., Suzuki N., Kikuchi H., Tanaka K., Kitagawa T. A new cationic liposome for efficient gene delivery with serum into cultured human cells: a quantitative analysis using two independent fluorescent probes. BBA-Biomembranes 2000, 1467:419-430.
33. Wender P.A., Galliher W.C., Goun E.A., Jones L.R., Pillow T.H. The design of guanidinium-rich transporters and their internalization mechanisms. Adv Drug Deliv Rev 2008, 60:452-472.
34. Tugyi R., Uray K., Iván D., Fellinger E., Perkins A., Hudecz F. Partial d-amino acid substitution: improved enzymatic stability and preserved Ab recognition of a MUC2 epitope peptide. Proc Natl Acad Sci U S A 2005, 102:413-418.
35. El-Sayed A., Khalil I.A., Kogure K., Futaki S., Harashima H. Octaarginine-and octalysine-modified nanoparticles have different modes of endosomal escape. J Biol Chem 2008, 283:23450-23461.
36. Won Y.W., Kim H.A., Lee M., Kim Y.H. Reducible poly (oligo-d-arginine) for enhanced gene expression in mouse lung by intratracheal injection. Mol Ther 2009, 18:734-742.
37. Jiang W., Kim B.Y.S., Rutka J.T., Chan W.C.W. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 2008, 3:145-150.
38. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Ipe B.I., et al. Renal clearance of quantum dots. Nat Biotechnol 2007, 25:1165-1170.
39. Wang S., Song H., Ong W.Y., Han M.Y., Huang D. Positively charged and pH self-buffering quantum dots for efficient cellular uptake by charge mediation and monitoring cell membrane permeability. Nanotechnology 2009, 20:425102-425110.
40. Chi E.Y., Krishnan S., Randolph T.W., Carpenter J.F. Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation. Pharm Res 2003, 20:1325-1336.
41. Henriques S.T., Melo M.N., Castanho M.A.R.B. Cell-penetrating peptides and antimicrobial peptides: how different are they?. Biochem J 2006, 399:1-7.
42. Zou S., Scarfo K., Nantz M.H., Hecker J.G. Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells. Int J Pharm 2010, 389:232-243.
43. Huang R.Q., Qu Y.H., Ke W.L., Zhu J.H., Pei Y.Y., Jiang C. Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. FASEB J 2007, 21:1117-1125.